Malignant Hepatobiliary Neoplasm
Conditions
Brief summary
This clinical trial studies whether Acceptance and Commitment Therapy can be used to help improve cancer distress for patients with hepatobiliary or breast cancers for which no treatment is currently available (incurable). Patients with hepatobiliary cancer (HBC) and breast cancer often experience high levels of distress and reductions in quality of life. Acceptance and Commitment Therapy for incurable cancers (ACT-C) is a behavioral intervention tailored to patients with incurable HBC and breast cancer. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.
Interventions
BEHAVIORALAcceptance and Commitment Therapy
Attend ACT-C telehealth group sessions
OTHERQuestionnaire Administration
Ancillary studies
OTHERTelemedicine
Attend ACT-C telehealth group sessions
Sponsors
Mayo Clinic
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Incurable HBC and breast cancer diagnosis * Age \>= 18 years * Able to provide written informed consent * Verbally endorse cancer distress * Access to the internet * Read and write in English * Reside in the states of Minnesota
Exclusion criteria
* Other psychological therapy that started =\< 2 months prior to prospective enrollment * Inability to actively participate in and learn from group therapy (e.g., active/uncontrolled psychotic symptoms, neurological condition, personality pathology) as determined by clinical judgement in Behavioral Medicine Program (BMP) consultation. Individual therapy or alternative group therapy will be offered to patients ineligible per this criterion * Cancer remission
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient satisfaction | At 8 weeks | The Institute for Healthcare Improvement 10-point Likert scale (0-10) asks: "Would you recommend this program to your friends and family?" A score ≥ 7 indicates high individual satisfaction. Program satisfaction is achieved if 50% of individuals meet this cut-off. |
| Patient session attendance (Feasibility) | At 8 weeks | Feasibility will be determined by the number of patients attending ≥ 4 sessions. |
Countries
United States
Contacts
CONTACTSofia Hammel
CONTACTDeanna Hofschulte
PRINCIPAL_INVESTIGATORCarrie A Bronars, PhD, LP
Mayo Clinic in Rochester
Outcome results
None listed